Screener
Rhythm Pharmaceuticals, Inc. RYTM Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies
Other financials
Where this comes from
Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.
The source filing: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-030549
| Line item | Three months ended March 31, 2026 | 2025 |
|---|---|---|
| Net loss attributable to common stockholders | $(56,743) | $(50,820) |
| Net loss per share attributable to common stockholders, basic and diluted | $(0.83) | $(0.81) |
| Weighted-average common shares outstanding, basic and diluted | 67,974,193 | 63,059,165 |
| Net loss | $(55,639) | $(50,820) |
| Other comprehensive income (loss): | ||
| Foreign currency translation adjustment | 1,784 | (2) |
| Unrealized gain (loss), net on marketable securities | $(544) | (10) |
| Comprehensive loss | $(54,399) | $(50,832) |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Rhythm Pharmaceuticals, Inc.'s comprehensive income (loss), net of tax, attributable to parent?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported comprehensive income (loss), net of tax, attributable to parent of -$54.4M in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s comprehensive income (loss), net of tax, attributable to parent decreased by 7.0% year-over-year, from -$50.83M to -$54.4M.
- What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s comprehensive income (loss), net of tax, attributable to parent?
- Over 4 years (2021 to 2025), Rhythm Pharmaceuticals, Inc.'s comprehensive income (loss), net of tax, attributable to parent has grown at a 30.7% compound annual growth rate (CAGR), from -$69.53M to -$202.67M.
- What does comprehensive income (loss), net of tax, attributable to parent mean?
- This metric represents the total change in equity from non-owner sources, including both net income and other comprehensive income items like foreign currency adjustments and unrealized gains on securities. It offers a more holistic view of the company's financial performance beyond traditional net income. Investors use this to assess the total impact of market and economic factors on the company's net worth.
Ask your AI about Rhythm Pharmaceuticals, Inc.'s comprehensive income (loss), net of tax, attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude